By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare today it has settled with Bio-Rad Laboratories over litigation related to GE Healthcare Life Sciences' technology for studying molecular interactions with surface plasmon resonance.

Financial terms of the settlement were not disclosed. In 2010 GE Healthcare sued Bio-Rad in Germany alleging infringement of SPR-related patents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.